ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

IMAB I MAB

1.76
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:01:32
15분 지연
기업명 주식 심볼 시장 주식 타입
I MAB IMAB 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 1.76 17:01:32
개장가 저가 고가 종가 전일 종가
1.76
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
22/05/202420:00PRNUSI-Mab to Participate at the Jefferies Global Healthcare..
30/04/202420:00PRNUSI-MAB Filed 2023 Annual Report on Form 20-F
05/04/202420:00PRNUSI-Mab to Participate at the 23rd Annual Needham Virtual..
03/04/202405:01PRNUSI-Mab Announces Closing of the Divestiture of Business..
15/03/202406:00PRNUSI-Mab Reports Full Year 2023 Financial Results and Business..
10/02/202406:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202420:07EDGAR2Form 144 - Report of proposed sale of securities
07/02/202420:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/02/202420:00PRNUSI-Mab Signs Agreement to Divest its Assets and Business..
07/02/202410:55EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
06/02/202420:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/01/202420:21EDGAR2Form 144 - Report of proposed sale of securities
03/01/202407:08DJNADRs Slump; FLJ Group Declines 21%
29/12/202320:12EDGAR2Form 144 - Report of proposed sale of securities
26/12/202320:22EDGAR2Form 144 - Report of proposed sale of securities
02/12/202304:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
16/11/202320:43EDGAR2Form 144 - Report of proposed sale of securities
06/11/202322:00PRNUSI-Mab Announces Participation at Jefferies and Piper..
02/11/202321:00PRNUSFelzartamab Granted Breakthrough Therapy Designation by U.S...
01/11/202321:00PRNUSI-Mab Announces Poster Presentations of 4-1BB Bispecific..
16/10/202321:00PRNUSI-Mab Announces Phase 1 Data of Givastomig at ESMO 2023
11/10/202300:04EDGAR2Form 144 - Report of proposed sale of securities
10/10/202321:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202321:00PRNUSI-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1BB..
29/09/202319:15EDGAR2Form 144 - Report of proposed sale of securities
23/09/202305:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/09/202321:00PRNUSI-Mab Announces Upcoming Participation at September..
17/08/202319:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/08/202319:00PRNUSI-Mab Provides Mid-Year 2023 Financial Results, Business and..
08/08/202321:00PRNUSI-Mab to Report Mid-Year 2023 Financial Results, Business..
11/07/202319:17EDGAR2Form 144 - Report of proposed sale of securities
05/07/202321:39EDGAR2Form 144 - Report of proposed sale of securities
05/07/202321:34EDGAR2Form 144 - Report of proposed sale of securities
05/07/202321:22EDGAR2Form 144 - Report of proposed sale of securities
05/07/202321:00PRNUSI-Mab Announces Publication of Claudin18.2 x 4-1BB..
22/06/202321:00PRNUSI-Mab Announces the Appointment of Raj Kannan as CEO
26/05/202306:01PRNUSI-Mab Announces Encouraging Phase 1b/2 Study Results of..